Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Heo, Jung Yeon | - |
dc.contributor.author | Song, Joon Young | - |
dc.date.accessioned | 2021-09-02T02:42:26Z | - |
dc.date.available | 2021-09-02T02:42:26Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2018-12 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/71475 | - |
dc.description.abstract | Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates. With the increasing prevalence of chronic medical conditions, a wide spectrum of healthcare-associated pneumonia could also affect the epidemiology of community-acquired pneumonia. Here, we provide an overview of the epidemiological changes associated with community-acquired pneumonia over the decades since pneumococcal conjugate vaccine introduction. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CHEMOTHERAPY | - |
dc.subject | CARE-ASSOCIATED PNEUMONIA | - |
dc.subject | CLINICAL-OUTCOMES | - |
dc.subject | HOSPITALIZED-PATIENTS | - |
dc.subject | RESISTANT PATHOGENS | - |
dc.subject | ANTIBIOTIC-THERAPY | - |
dc.subject | HERD PROTECTION | - |
dc.subject | ECONOMIC BURDEN | - |
dc.subject | POPULATION | - |
dc.subject | GUIDELINE | - |
dc.subject | ADMISSIONS | - |
dc.title | Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Joon Young | - |
dc.identifier.doi | 10.3947/ic.2018.50.4.287 | - |
dc.identifier.scopusid | 2-s2.0-85059535469 | - |
dc.identifier.wosid | 000454653900001 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, v.50, no.4, pp.287 - 300 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 50 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 287 | - |
dc.citation.endPage | 300 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002423743 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | CARE-ASSOCIATED PNEUMONIA | - |
dc.subject.keywordPlus | CLINICAL-OUTCOMES | - |
dc.subject.keywordPlus | HOSPITALIZED-PATIENTS | - |
dc.subject.keywordPlus | RESISTANT PATHOGENS | - |
dc.subject.keywordPlus | ANTIBIOTIC-THERAPY | - |
dc.subject.keywordPlus | HERD PROTECTION | - |
dc.subject.keywordPlus | ECONOMIC BURDEN | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | GUIDELINE | - |
dc.subject.keywordPlus | ADMISSIONS | - |
dc.subject.keywordAuthor | Pneumonia | - |
dc.subject.keywordAuthor | Incidence | - |
dc.subject.keywordAuthor | Mortality | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Pneumococcal conjugate vaccine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.